Disentangling the multiple links between renal dysfunction and cerebrovascular disease

Dearbhla Kelly1, Peter Malcolm Rothwell2

  • 1Centre for the Prevention of Stroke and Dementia, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK Dearbhla.Kelly@ndcn.ox.ac.uk.

Insights

Chronic kidney disease (CKD) significantly increases stroke risk. This review explores the link between kidney disease and cerebrovascular issues, including potential causes and impacts on stroke treatment.

Area of Science:

  • Nephrology and Neurology
  • Epidemiology of Chronic Diseases
  • Cardiovascular and Cerebrovascular Health

Background:

  • Chronic kidney disease (CKD) prevalence is rising globally, particularly in older adults.
  • CKD is a significant risk factor for cardiovascular disease, especially stroke.
  • Associations exist between CKD and subclinical cerebrovascular abnormalities, cognitive impairment, and dementia.

Purpose of the Study:

  • To review the current understanding of cerebrovascular disease epidemiology in CKD patients.
  • To explore the pathophysiology linking CKD to cerebrovascular complications.
  • To discuss the role of traditional and non-traditional risk factors in this association.

Main Methods:

  • Review of cohort studies and clinical trials.
  • Analysis of epidemiological data on CKD and stroke incidence.
  • Examination of pathophysiological mechanisms and risk factors.

Main Results:

  • Reduced glomerular filtration rate increases stroke risk by approximately 40%.
  • Proteinuria elevates stroke risk by approximately 70%.
  • CKD is linked to both traditional (hypertension, diabetes) and non-traditional (uremia, oxidative stress) risk factors.

Conclusions:

  • CKD poses a substantial risk for cerebrovascular disease, including stroke and cognitive decline.
  • Multiple traditional and non-traditional factors contribute to the CKD-cerebrovascular link.
  • Understanding these mechanisms is crucial for managing stroke risk and treatment in CKD patients.

Related Concept Videos

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats06:38

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats

Early stage hemodynamic dysfunction is critical to the development of kidney disease. Yet, detection methodologies are limited. Recent advances in sonography provide a noninvasive, accurate option for early detection of kidney injury. This study outlines a step-by-step, sonographic methodology for detecting kidney dysfunction using a drug-induced nephrotoxicity rat model.
12.5K
A Visual Approach for Inducing Dolichoectasia in Mice to Model Large Vessel-Mediated Cerebrovascular Dysfunction04:29

A Visual Approach for Inducing Dolichoectasia in Mice to Model Large Vessel-Mediated Cerebrovascular Dysfunction

We demonstrate chemically inducing large blood vessel dilatation in mice as a model for investigating cerebrovascular dysfunction, which can be used for vascular dementia and Alzheimer's disease modeling. We also demonstrate visualizing the vasculature by injecting silicone rubber compound and providing clear visual guidance for measuring changes in blood vessel...
1.2K
Mapping Dysfunctional Protein-Protein Interactions in Disease09:39

Mapping Dysfunctional Protein-Protein Interactions in Disease

Here, we present a protocol to enable the capture and identification of disease-specific protein-protein interactions from native cells and tissues using chemical probes and mass spectrometry. The resulting interaction datasets are analyzed through a dedicated web-based platform to reveal dynamic network dysfunctions and pathway alterations linked to...
607
Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Here, we present a protocol to assess whether various types of silent cerebrovascular lesions are differentially associated with deficits in certain cognitive domains in a cohort of 398 hypertensive elderly Chinese, using a combination of neuropsychological tests and multi-sequence 3T MRI...
3.4K
In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease07:03

In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease

This article describes the use of oleic acid-induced HepG2 cells as a model for metabolic dysfunction-associated steatotic liver...
1.6K
Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis06:26

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Mouse model of metabolic dysfunction-associated steatotic liver disease (MASLD) with metabolic dysfunction, hepatic gene expression changes, and liver histopathological alterations that resemble human MASLD, including fibrosis that progresses to advanced fibrosis stage 3. This model can be used in studies of MASLD pathophysiology and in pre-clinical studies of new therapies.
720